...
首页> 外文期刊>Molecular & cellular proteomics: MCP >Quantification of HER2 by Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded (FFPE) Breast Cancer Tissues.
【24h】

Quantification of HER2 by Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded (FFPE) Breast Cancer Tissues.

机译:福尔马林固定石蜡包埋(FFPE)乳腺癌组织中靶向质谱定量HER2。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The ability to accurately quantify proteins in formalin-fixed paraffin-embedded tissues using targeted mass spectrometry opens exciting perspectives for biomarker discovery. We have developed and evaluated a selectedreaction monitoring assay for the human receptor tyrosine-protein kinase erbB-2 (HER2) in formalin-fixed paraffin-embedded breast tumors. Peptide candidates were identified using an untargeted mass spectrometry approach in relevant cell lines. A multiplexed assay was developed for the six best candidate peptides and evaluated for linearity, precision and lower limit of quantification. Results showed a linear response over a calibration range of 0.012 to 100 fmol on column (R(2): 0.99-1.00).The lower limit of quantification was 0.155 fmol on column for all peptides evaluated. The six HER2 peptides were quantified by selected reaction monitoring in a cohort of 40 archival formalin-fixed paraffin-embedded tumor tissues from women with invasive breast carcinomas, which showed different levels of HER2 gene amplification as assessed by standard methods used in clinical pathology. The amounts of the six HER2 peptides were highly and significantly correlated with each other, indicating that peptide levels can be used as surrogates of protein amounts in formalin-fixed paraffin-embedded tissues. After normalization for sample size, selected reaction monitoring peptide measurements were able to correctly predict 90% of cases based on HER2 amplification as defined by the American Society of Clinical Oncology and College of American Pathologists. In conclusion, the developed assay showed good analytical performance and a high agreement with immunohistochemistry and fluorescence in situ hybridization data. This study demonstrated that selected reaction monitoring allows to accurately quantify protein expression in formalin-fixed paraffin-embedded tissues and represents therefore a powerful approach for biomarker discovery studies. The untargeted mass spectrometry data is available via ProteomeXchange whereas the quantification data by selected reaction monitoring is available on the Panorama Public website.
机译:使用靶向质谱法精确定量福尔马林固定石蜡包埋的组织中蛋白质的能力为生物标记物发现打开了令人兴奋的前景。我们已经开发并评估了福尔马林固定石蜡包埋的乳腺肿瘤中人类受体酪氨酸蛋白激酶erbB-2(HER2)的选择性反应监测方法。在相关细胞系中使用非靶向质谱法鉴定了候选肽。针对六个最佳候选肽开发了一种多重检测方法,并对其线性,精密度和定量下限进行了评估。结果显示,色谱柱在0.012至100 fmol的校准范围内具有线性响应(R(2):0.99-1.00)。所有评估的肽段的定量下限为0.155 fmol。通过在来自浸润性乳腺癌妇女的40份福尔马林固定石蜡包埋的肿瘤组织队列中进行选择的反应监测,对这6种HER2肽进行了定量,如通过临床病理学中使用的标准方法所评估的,这些组织显示出不同水平的HER2基因扩增。六个HER2肽的量彼此高度相关且显着相关,表明该肽水平可以用作福尔马林固定石蜡包埋的组织中蛋白质量的替代物。将样本量标准化后,根据美国临床肿瘤学会和美国病理学家学院的定义,选择的反应监测肽测量值能够根据HER2扩增正确预测90%的病例。总之,开发的检测方法显示出良好的分析性能,并且与免疫组织化学和荧光原位杂交数据高度吻合。这项研究表明,选择的反应监测可以准确定量福尔马林固定石蜡包埋的组织中的蛋白质表达,因此代表了生物标记物发现研究的有力方法。非目标质谱数据可通过ProteomeXchange获得,而通过选定的反应监测获得的定量数据可在Panorama Public网站上获得。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号